MENU
LGND
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ligand Pharmaceuticals (LGND) Ownership - Who owns Ligand Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
555 Heritage Drive
Phone
+1 858 550-7500
Employees
58
Web
https://www.ligand.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.28B
P/E Ratio
48.37
Total Cash
219.64M
Projected Growth
N/A
Total Debt
7.36M
Revenue
152.42M
Risk (Beta)
1.10
Dividend Yield
N/A
Total Cash/Share
11.62
Total Debt/Equity
8.88
Revenue/Share
8.31 USD as % of share price
Fundamentals
LGND
Capitalization
2.28B
P/E Ratio
48.37
Risk (Beta)
1.10
Dividend Yield
N/A
Total Cash
220M
Total Cash/Share
11.62
Total Debt
7.36M
Total Debt/Equity
8.88
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
8.31%
Revenue
152M
ROE
N/A
Book Value
841M
P/B Ratio
2.70
Cash Flow
N/A
Earnings
2.55
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
19K
Current Ratio
12.49
Current Revenue Per Employee
893310.40
Dividends Per Share - Security
N/A
EBITDA
95.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
95.27
Revenue To Assets
5.25
Shares Held By Institutions
3.63B
Shares Outstanding - Current
18.9M
Total Liabilities
114M
Total Volume MTD
N/A
Value
-1
Gain YTD
68.622
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
555 Heritage Drive
Phone
+1 858 550-7500
Employees
58
Web
https://www.ligand.com